These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26321081)

  • 1. Low Osteopontin N-Terminal Fragment and Carotid Plaque Stability Associated with Statin or Antiplatelet Therapy.
    Hamias R; Volvich L; Paran E; Sion-Vardi N; Novack V; Szendro G; Greenberg G; Rudich A; Wolak T
    Curr Vasc Pharmacol; 2016; 14(3):288-94. PubMed ID: 26321081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal rather than full-length osteopontin or its C-terminal fragment is associated with carotid-plaque inflammation in hypertensive patients.
    Wolak T; Sion-Vardi N; Novack V; Greenberg G; Szendro G; Tarnovscki T; Nov O; Shelef I; Paran E; Rudich A
    Am J Hypertens; 2013 Mar; 26(3):326-33. PubMed ID: 23382482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
    Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
    Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy.
    Verhoeven BA; Moll FL; Koekkoek JA; van der Wal AC; de Kleijn DP; de Vries JP; Verheijen JH; Velema E; Busser E; Schoneveld A; Virmani R; Pasterkamp G
    Stroke; 2006 Aug; 37(8):2054-60. PubMed ID: 16809559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin treatment is associated with reduced toll-like receptor 4 immunohistochemical expression on carotid atherosclerotic plaques: a novel effect of statins.
    Katsargyris A; Klonaris C; Tsiodras S; Bastounis E; Giannopoulos A; Theocharis S
    Vascular; 2011 Dec; 19(6):320-6. PubMed ID: 21903856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of instability in high-risk carotid plaques are reduced by statins.
    Kunte H; Amberger N; Busch MA; Rückert RI; Meiners S; Harms L
    J Vasc Surg; 2008 Mar; 47(3):513-22. PubMed ID: 18295103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative Antiplatelet and Statin Use Does Not Affect Outcomes after Carotid Endarterectomy.
    Krafcik BM; Farber A; Eberhardt RT; Kalish JA; Rybin D; Doros G; Pike SL; Siracuse JJ
    Ann Vasc Surg; 2018 Jan; 46():43-52. PubMed ID: 29100876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of carotid atherosclerotic plaques by vascular plaque quantification (VPQ) technology of three-dimensional ultrasonography].
    Xing HY; Chen YH; Xu K; Huang DD; Peng Q; Liu R; Sun W; Huang YN
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):991-999. PubMed ID: 36241243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.
    Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Liapis CD
    J Vasc Surg; 2010 Jan; 51(1):114-21. PubMed ID: 19837545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription of Guideline-Based Medical Therapies at Discharge After Carotid Artery Stenting and Endarterectomy: An NCDR Analysis.
    Aronow HD; Kennedy KF; Wayangankar SA; Katzen BT; Schneider PA; Abou-Chebl A; Rosenfield KA
    Stroke; 2016 Sep; 47(9):2339-46. PubMed ID: 27507868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis.
    Lenglet S; Quercioli A; Fabre M; Galan K; Pelli G; Nencioni A; Bauer I; Pende A; Python M; Bertolotto M; Spinella G; Pane B; Palombo D; Dallegri F; Mach F; Vuilleumier N; Montecucco F
    Mediators Inflamm; 2014; 2014():720987. PubMed ID: 24648660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of NPP1 is regulated during atheromatous plaque calcification.
    Nitschke Y; Hartmann S; Torsello G; Horstmann R; Seifarth H; Weissen-Plenz G; Rutsch F
    J Cell Mol Med; 2011 Feb; 15(2):220-31. PubMed ID: 20015201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability.
    Erbel C; Dengler TJ; Wangler S; Lasitschka F; Bea F; Wambsganss N; Hakimi M; Böckler D; Katus HA; Gleissner CA
    Basic Res Cardiol; 2011 Jan; 106(1):125-34. PubMed ID: 21116822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carotid atherosclerotic plaque stenosis: the stabilizing role of statins.
    Artom N; Montecucco F; Dallegri F; Pende A
    Eur J Clin Invest; 2014 Nov; 44(11):1122-34. PubMed ID: 25231921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3, Carotid Plaque Vulnerability, and Potential Effects of Statin Therapy.
    Kadoglou NP; Sfyroeras GS; Spathis A; Gkekas C; Gastounioti A; Mantas G; Nikita KS; Karakitsos P; Liapis CD
    Eur J Vasc Endovasc Surg; 2015 Jan; 49(1):4-9. PubMed ID: 25457298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis.
    Kadoglou NP; Gerasimidis T; Kapelouzou A; Moumtzouoglou A; Avgerinos ED; Kakisis JD; Karayannacos PE; Liapis CD
    Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):258-65. PubMed ID: 20004120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis.
    Kadoglou NP; Gerasimidis T; Moumtzouoglou A; Kapelouzou A; Sailer N; Fotiadis G; Vitta I; Katinios A; Kougias P; Bandios S; Voliotis K; Karayannacos PE; Liapis CD
    Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):661-8. PubMed ID: 18395477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of symptomatic carotid atherosclerotic plaques by statins: a clinico-pathological analysis.
    Konishi T; Funayama N; Yamamoto T; Hotta D; Nomura R; Nakagaki Y; Murahashi T; Kamiyama K; Yoshimoto T; Aoki T; Tanaka S
    Heart Vessels; 2018 Nov; 33(11):1311-1324. PubMed ID: 29789903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin 1-7, but not the thrombin-cleaved osteopontin C-terminal fragment, attenuates osteopontin-mediated macrophage-induced endothelial-cell inflammation.
    Hamias R; Rudich A; Greenberg G; Szendro G; Wolak T
    Inflamm Res; 2018 Mar; 67(3):265-275. PubMed ID: 29181544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin and osteoprotegerin in atherosclerotic plaque - are they significant markers of plaque vulnerability?
    Strobescu-Ciobanu C; Giuşcă SE; Căruntu ID; Amălinei C; Rusu A; Cojocaru E; Popa RF; Lupaşcu CD
    Rom J Morphol Embryol; 2020; 61(3):793-801. PubMed ID: 33817720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.